Community Health Systems
NYSE: CYH
$3.30 ▼ -0.09  (-2.51%)
At close: Jul 17, 2026 · 3:59 PM UTC
Financial Ratios
Market Cap3.55 Mn
P/E0.01
P/S0.00
Div. Yield7.04
ROIC (Qtr)0.00
Total Debt (Qtr)10.16 Bn
Revenue Growth (1y) (Qtr)-6.14
Add ratio to table…

About

Community Health Systems, Inc. is one of the nation’s largest healthcare companies. Its affiliates operate as leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. At the end of 2025, the company’s subsidiaries owned or leased 69 affiliated hospitals with more than 10,000 beds and operated over 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency…

Read more ↓
Sector: Healthcare Industry: Medical Care Facilities CIK: 0001108109

Investment Thesis

▲ Bull case
  • Debt reduction via tender offer improves leverage and interest expense freeing cash for growth and reducing financial risk. The company accepted approximately 368 million of its 2031 notes and 231 million of its 2032 notes at prices below par for the lower coupon issue and slightly above par for the high coupon issue. This transaction reduces the outstanding debt principal and lowers the annual interest outflow. As a result the leverage ratio declined to 6.5 times at quarter end from 6.6 times at the prior year end. The stronger balance sheet provides capacity to fund future investments or to weather any temporary downturn in operating performance.
  • Ambulatory surgery center investments expand higher margin outpatient capacity positioning the company to capture delayed elective procedures as volume recovers. The pending acquisition of a majority stake in the Surgical Institute of Alabama adds a facility that performs more than eight thousand cases annually and is the largest multi specialty surgery center in the state. Additional purchases in Alaska and two de novo centers in Birmingham and Foley Alabama further broaden the outpatient footprint. These sites typically generate better contribution margins than inpatient services because of lower overhead and favorable payer contracts. As postponed surgeries return the company is positioned to convert this demand into profitable growth.
  • Quality improvement initiatives shown by expected Leapfrog and CMS rating upgrades suggest better reimbursement rates and market share gains. Management anticipates that as many as eighty% of hospitals will receive a Leapfrog A or B grade when the spring 2026 results are released up from forty eight% a year earlier. Similarly the proportion of hospitals earning a CMS rating of three or more stars is projected to rise to fifty six% from forty five% in the prior year. Higher safety and quality scores often translate into higher payments from government programs and commercial insurers. Improved reputation also helps attract physicians and patients to the company's facilities.
  • Physician experience investments such as ambient listening technology net physician hiring and in sourced anesthesia reduce administrative burdens and improve capacity to serve returning patient demand. The deployment of ambient listening tools in clinics and hospitals aims to cut down the time physicians spend on documentation and increase face to face interaction with patients. During the quarter the company added thirty net physicians reflecting successful recruitment and lower turnover. The in sourced anesthesia program introduced in late 2025 contributes to greater control over service delivery and cost structure. Together these actions build a stronger platform to handle a rebound in elective procedure volumes.
  • State directed payment programs and rural health transformation fund present potential upside not yet reflected in guidance especially given the company's rural footprint. The recently approved Georgia state directed payment program contributed about thirty million dollars of revenue and twenty five million dollars of EBITDA in the quarter representing nine months of benefit. Management notes that additional states may adopt similar programs or enhance existing ones over the coming months. The rural health transformation fund is designed to direct money toward providers serving underserved communities matching the company's historic market focus. If these funding streams materialize they could lift earnings beyond the current forecast range.
▼ Bear case
  • Persistent payer mix pressure from high deductible commercial and exchange plans driven by managed care preauthorization denials may suppress volumes longer than anticipated. Management acknowledged that volume pressures were broad based and particularly evident in individuals with commercial and health exchange coverage. The behavior of managed care organizations that increase denial rates for preauthorizations keeps many potential patients from even reaching the hospital doors. This dynamic reduces admissions for elective procedures such as hip and knee replacements which are sensitive to cost sharing. If these restrictions persist the expected rebound in demand could be delayed or weakened.
  • Rising self pay volumes and potential collection difficulties increase bad debt risk pressuring margins despite revenue growth. The quarter saw an increase in self pay volumes as a percentage of total revenue reflecting higher patient responsibility for costs. Collecting co pays and deductibles from this population has historically been more challenging than from insured patients. An uptick in self pay without a corresponding improvement in collection efficiency can lead to higher bad debt expenses. This trend would erode the benefit of any top line growth from rate increases or volume recovery.
  • Labor cost inflation from physician employment and in sourced services raises operating expenses offsetting benefits from volume recovery. The company added thirty net physicians during the quarter increasing salary and benefit expenses. In sourced anesthesia introduced in late 2025 added further to the labor cost base. Salaries and benefits as a percentage of revenue rose by fifty basis points on a same store basis reflecting these investments. While these moves improve long term capacity they also increase the fixed cost burden in the short term.
  • Reliance on timing of Medicaid supplemental payments and provider tax settlements creates earnings volatility and could reverse if state programs change. The first quarter benefited from approximately twenty five million dollars of out of period revenue from the Georgia state directed payment program. This benefit was partially offset by out of period provider tax increases related to the Indiana program. Such timing differences cause reported EBITDA to fluctuate quarter to quarter independent of underlying operations. If state legislatures alter the structure or funding levels of these programs the company could lose a meaningful source of earnings.
  • High leverage remaining at 6.5x and near term debt maturities limit financial flexibility and increase sensitivity to interest rate changes. Although leverage decreased slightly from 6.6 times at the prior year end to 6.5 times at quarter end the level remains elevated for the industry. The next significant maturity is not until 2029 but the company still faces annual interest obligations on a substantial debt base. A rise in market interest rates would raise the cost of servicing the existing notes especially the higher coupon 2032 issue. Limited financial flexibility could constrain the ability to pursue acquisitions or return capital to shareholders.

Peer Comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HCA HCA Healthcare, Inc. 87.94 Bn11.251.1548.02 Bn
2 CHE Chemed Corp 18.08 Bn51.687.120.09 Bn
3 THC Tenet Healthcare Corp 16.59 Bn9.740.7713.21 Bn
4 DVA Davita Inc. 15.37 Bn14.021.1010.63 Bn
5 EHC Encompass Health Corp 10.07 Bn654.201.662.57 Bn
6 ENSG Ensign Group, Inc 9.52 Bn27.181.810.14 Bn
7 UHS Universal Health Services Inc 9.19 Bn6.050.524.71 Bn
8 PACS PACS Group, Inc. 6.96 Bn28.551.280.05 Bn